Invitation to Presentation on the recent Ethics Committee Approval and Clinical Strategy
We are delighted to extend an invitation to you for an insightful presentation hosted by Scandinavian ChemoTech featuring distinguished speakers: MD Suhail Mufti, CEO Mohan Frick, and Chairman of the Board Robin Sukhia. The event will take place on Monday, January 29th, and will focus on the recent approval of the amended study protocol for Head & Neck cancer and its implications for our clinical strategy, as well as the potential impact on our commercial opportunities. Additionally, there will be an interactive opportunity for attendees to ask questions and gain further clarity on